Interview with David Hite, CEO, Alandra Medical México
Before we get into the company’s activities and market, could you give us a brief rundown of your past working experience prior to Alandra Medical? My experience outside of the…
Address: Av San Barnabé 123 col. San Jeronimo lidice CP 10200 México DF,Mexico
Tel: +52 55 5377 3198
Web: http://www.alandramedical.com/
ALANDRA Medical is at the forefront of the offshore medical device innovation ecosystem. We are a medical device company that specializes in Capital Efficiency. At ALANDRA Medical we are dedicated to the research, design and development, and clinical trials of new medical devices. We are an interdisciplinary group of engineers, designers, scientists and medical doctors, providing a compelling suite of core services in the development, testing and clinical trials of new medical devices and medical equipment. Our team has contributed to medical device and medical equipment development in diabetes, cardiology, neurology, minimally-invasive surgery, anesthesiology, critical care, electromagnetic therapy and audiology.
ALANDRA MEDICAL has two core divisions to manage the design, development and research processes for medical devices and medical equipment: Design & Development and CRO & Clinical Validation
Before we get into the company’s activities and market, could you give us a brief rundown of your past working experience prior to Alandra Medical? My experience outside of the…
Ana Riquelme Francistain, executive director of the MedTech trade group Asociación Mexicana de Industrias Innovadoras de Dispositivos Médicos (AMID), details the trade and tax incentives that have favoured nearshoring from…
Four years ago, Daniel Del Conde left a career in multinational pharma to become the CEO of regional player Grupo Somar. He walks us through the company’s activities – private…
While the COVID-19 pandemic revealed vulnerabilities that sent many organizations looking for ways to bring supply chains closer to home, geopolitical tensions have also encouraged companies to avoid dependence on…
In a move to address medicine shortages Mexico’s outgoing president Andrés Manuel López Obrador last year launched a Super Pharmacy, or “Megafarmacia del Bienestar,” dubbed the largest medicine stockpile n…
The latest stories from Mexican pharma and healthcare, including Sanfer’s purchase of Colombia-based manufacturer Vitalis; Organon Mexico’s new business; the FDA’s warning to Glicerinas Industriales, and a look at the issues,…
Mexican voters will be heading to the polls next June for what will be the largest election process in the country’s history with concurrent state and federal elections. The election will…
The latest from Mexican pharma, including the distribution agreement between Dow and Azelis, Neuraxpharm’s new LatAm subsidiaries in Mexico and Brazil; Landsteiner Scientific’s restructure, and Merck’s plant expansion in Naucalpan.…
Latin America’s patient organisations are today playing a more important role than ever before in developing solutions to the continent’s most pressing healthcare challenges. Given the healthcare gaps that persist,…
Back in Latin America after several years in the US and Europe, Teva LatAm Head and Mexico GM Rodrigo Fernandez explains how the affiliate has adapted its strategy across the…
Mexico, with the second largest pharmaceutical market in Latin America, has a number of strong local pharma industry players. These companies, no longer focused solely on the domestic market, are…
María del Socorro España Lomelí, the executive director of Mexico’s National Association of Manufacturers of Medicines (ANAFAM), speaks to PharmaBoardroom about ANAFAM’s evolving relationship with the Mexican government and the…
Dagoberto Cortés Cervantes, president of Mexico’s National Association of Medicines Manufacturers (ANAFAM) and director of Grupo Sanfer/Hormona Mexico, outlines the expansion strategy that has led the manufacturing group to extend…
See our Cookie Privacy Policy Here
